HN2002000278A - Tetrahidroquinolinas - Google Patents

Tetrahidroquinolinas

Info

Publication number
HN2002000278A
HN2002000278A HN2002000278A HN2002000278A HN2002000278A HN 2002000278 A HN2002000278 A HN 2002000278A HN 2002000278 A HN2002000278 A HN 2002000278A HN 2002000278 A HN2002000278 A HN 2002000278A HN 2002000278 A HN2002000278 A HN 2002000278A
Authority
HN
Honduras
Prior art keywords
tetrahydroquinolins
medicines
procedures
preparation
present
Prior art date
Application number
HN2002000278A
Other languages
English (en)
Spanish (es)
Inventor
Heike Gielen
Siegfried Golmann
Keldenich Jorg
Holger Paulsen
Carsten Schmeck
Stephan Siegel
Hilmar Bischoff
Martin Raabe
Delf Schmidt
Christiane Faeste
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HN2002000278A publication Critical patent/HN2002000278A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
HN2002000278A 2001-10-01 2002-10-01 Tetrahidroquinolinas HN2002000278A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10148436A DE10148436A1 (de) 2001-10-01 2001-10-01 Tetrahydrochinoline

Publications (1)

Publication Number Publication Date
HN2002000278A true HN2002000278A (es) 2002-12-20

Family

ID=7701007

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000278A HN2002000278A (es) 2001-10-01 2002-10-01 Tetrahidroquinolinas

Country Status (12)

Country Link
US (1) US20050043341A1 (https=)
EP (1) EP1434581A1 (https=)
JP (1) JP2005508341A (https=)
AR (1) AR036583A1 (https=)
CA (1) CA2462030A1 (https=)
DE (1) DE10148436A1 (https=)
DO (1) DOP2002000457A (https=)
GT (1) GT200200195A (https=)
HN (1) HN2002000278A (https=)
PE (1) PE20030604A1 (https=)
UY (1) UY27458A1 (https=)
WO (1) WO2003028727A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003357A (es) * 2003-09-26 2006-06-08 Japan Tobacco Inc Metodo para inhibir la produccion de lipoproteina remanente.
DE602004023100D1 (de) 2003-10-08 2009-10-22 Lilly Co Eli Verbindungen und verfahren zur behandlung von dyslipidemie
JP2007530550A (ja) 2004-03-26 2007-11-01 イーライ リリー アンド カンパニー 異脂肪血症を治療するための化合物および方法
ES2384980T3 (es) * 2004-12-18 2012-07-16 Bayer Pharma Aktiengesellschaft Derivados de tetrahidroquinolina sustituidos en 4 con cicloalquilo y su uso como medicamentos
BRPI0519566A2 (pt) * 2004-12-18 2009-01-27 Bayer Healthcare Ag derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp
DE102006012548A1 (de) 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
CN101096363B (zh) * 2006-06-27 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途
US20080145498A1 (en) * 2006-12-14 2008-06-19 Kraft Foods Holdings, Inc. Texture and shape control process for acidified food products
BRPI0909105A2 (pt) * 2008-03-05 2015-08-25 Boehringer Ingelheim Int Derivados de piridina tricíclicos, composição farmacêutica e uso dos mesmos, bem como processos para preparar os ditos compostos e a dita composição farmacêutica
UY33229A (es) * 2010-02-19 2011-09-30 Boehringer Ingelheim Int Derivados de piridina tricíclicos, medicamentos que contienen tales compuestos, su uso y proceso pa ra su preparación
CA2804924C (en) 2010-07-09 2016-06-28 Daiichi Sankyo Company, Limited Substituted pyridine compound
EP2760868B1 (en) 2011-08-17 2018-04-25 Boehringer Ingelheim International GmbH Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
TWI570118B (zh) 2012-01-06 2017-02-11 第一三共股份有限公司 經取代之吡啶化合物的酸加成鹽
JP6742316B2 (ja) 2014-09-09 2020-08-19 ベーリンガー インゲルハイム インターナショナル トレイディング （シャンハイ） カンパニー リミテッド スピロ［２．５］オクタン−５，７−ジオンおよびスピロ［３．５］ノナン−６，８−ジオンの調製のための新規なプロセス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP970330B1 (en) * 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines
MA24643A1 (fr) * 1997-09-18 1999-04-01 Bayer Ag Tetrahydro-naphtalenes substitues et composes analogues
DE19741051A1 (de) * 1997-09-18 1999-03-25 Bayer Ag Hetero-Tetrahydrochinoline
DE19741399A1 (de) * 1997-09-19 1999-03-25 Bayer Ag Tetrahydrochinoline

Also Published As

Publication number Publication date
GT200200195A (es) 2003-08-22
US20050043341A1 (en) 2005-02-24
WO2003028727A9 (de) 2003-11-13
DE10148436A1 (de) 2003-04-17
JP2005508341A (ja) 2005-03-31
WO2003028727A1 (de) 2003-04-10
CA2462030A1 (en) 2003-04-10
DOP2002000457A (es) 2003-04-15
UY27458A1 (es) 2003-04-30
PE20030604A1 (es) 2003-09-07
AR036583A1 (es) 2004-09-15
EP1434581A1 (de) 2004-07-07

Similar Documents

Publication Publication Date Title
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
ITTO20010008A0 (it) Formulazione farmaceutica
HN2002000150A (es) Agentes antibacteriano
NO20071303L (no) Farmasoytiske preparater
NO20033556D0 (no) Farmasöytiske preparater
ATE355271T1 (de) Pharmazeutische zusammensetzung
NO20033384D0 (no) Farmasöytisk formulering
EE200300416A (et) Ravimvorm
HN2002000300A (es) Nuevos derivados de piperazina
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
HN2002000278A (es) Tetrahidroquinolinas
NO20035627D0 (no) Farmasöytisk formulering
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
BR0114254B1 (pt) distractor maxilar para modificação da distáncia entre o maxilar e o zigoma.
ATE366128T1 (de) Pharmazeutische zusammensetzung
DE50108437D1 (de) Flachflächen-Schnellkupplung
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
UY26556A1 (es) Compuestos calcilíticos
ES1050889Y (es) Articulo para masticar
DE10291905D2 (de) Pharmazeutische Zusammensetzung
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
DE10107261B4 (de) Pharmazeutische Zusammensetzung
EP1413314A4 (en) MEDICAL COMPOSITIONS
HN2002000052A (es) Derivados de difenilo
HN2002000049A (es) Nuevos compuestos antiinflamatorios de triazolopiridinas